"Sanford Worthington Cancer Center in Worthington, MN has a team approach to cancer care, including diagnostics, surgery, radiation oncology, medical oncology, chemotherapy and survivorship."

During the past decade, Sanford Cancer Center Worthington conducted 78 clinical trials. In the 10-year time frame, 78 clinical trials started and 10 clinical trials were completed, i.e. on average, 12.8% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 10 clinical trials were completed. i.e. 27% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sanford Cancer Center Worthington" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 12 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored and "Wake Forest University Health Sciences" with 8 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sanford Cancer Center Worthington" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Sanford Cancer Center Worthington" are "Stage IV Lung Cancer AJCC v8" (6 trials), "Lung Non-Squamous Non-Small Cell Carcinoma" (4 trials), "Stage IVA Lung Cancer AJCC v8" (4 trials), "Stage IVB Lung Cancer AJCC v8" (4 trials) and "Anal Basaloid Carcinoma" (3 trials). Many other conditions were trialed in "Sanford Cancer Center Worthington" in a lesser frequency.

Most popular intervention types in "Sanford Cancer Center Worthington" are "Drug" (56 trials), "Other" (53 trials), "Biological" (31 trials), "Procedure" (26 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (24 trials), "Questionnaire Administration" (19 trials), "Nivolumab" (17 trials), "Biospecimen Collection" (15 trials) and "Computed Tomography" (15 trials). Other intervention names were less common.

The vast majority of trials in "Sanford Cancer Center Worthington" are 73 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Sanford Cancer Center Worthington". undefined are not yet recruiting, 34 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Sanford Cancer Center Worthington, 3 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Sanford Cancer Center Worthington, 2 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".